Skip to content Skip to footer

Best CT and MRI Contrast Media Calculator

Best CT and MRI Contrast Media Calculator | SATMED Health

Best CT and MRI Contrast Media Calculator

Optimize clinical workflows with our advanced contrast media calculator, designed for precise, patient-specific dosing of CT iodinated contrast and MRI gadolinium-based agents. Streamline your imaging protocols with built-in tools for Lean Body Weight (LBW), BSA, and eGFR safety assessments. Access precise injection profiles, real-time pressure curves, and institutional annual volume projections to reduce contrast waste and ensure accurate CT contrast dose and gadolinium dose calculations every time.

CT Iodinated Contrast Calculator

💉
Patient Parameters
Enter patient data for personalized dosing
Actual body weight
Required for LBW & BSA
Required for eGFR
Required for eGFR (CKD-EPI)
Typical: 3-5 mL/s for CTA
Saline chaser volume
Average daily contrast injections
For cost analysis
Standard fixed dose for comparison

Complete Patient Dose Analysis

📐
Patient Metrics
Body composition & renal function
--Lean Body Weight (kg)
--BSA (m2)
--eGFR (mL/min/1.73m2)
--Renal Risk Category
💉
Contrast Dose
Calculated volume & iodine load
--Total Volume (mL)
--Iodine Load (g I)
--IDR (g I/s)
--Injection Duration (s)
📈
AI Injection Profile
Real-time viscosity, velocity & pressure prediction
LIVEViscosityVelocity
Contrast Flow (mL/s)
Saline Flush (mL/s)
Pressure (psi)
Max Pressure Limit
Viscosity (cP)
Velocity (cm/s)
--Total Injection Duration (contrast + saline)
--Estimated Max Pressure (psi)
--Saline Flush Duration (s)
--Peak Viscosity (cP)
--Peak Velocity (cm/s)
--Reynolds Number
💰
Cost Comparison: Patient-Specific vs Fixed Dose
Per-patient and annual savings analysis
--Fixed Volume (mL)
--Patient Volume (mL)
--Volume Diff
--Fixed Cost
--Patient Cost
--Cost Diff
--Fixed Waste (mL)
--Patient Waste (mL)
--Waste Diff
--Fixed Iodine (g)
--Patient Iodine (g)
--Iodine Diff
--Savings per Patient ($)
--Daily Savings ($)
--Annual Savings ($)
--Annual Volume Saved (L)

Annual Volume Projection per Scanner

--Total Annual Volume (L)
--Total Annual Cost ($)
--Fixed Dose Annual Vol (L)
--Fixed Dose Annual Cost ($)
--Annual Cost Savings ($)
--Annual Volume Saved (L)

Protocol recommendation will appear here.

CT Contrast Protocol Reference

Exam TypeIodine Dose (mg I/kg)IDR (g I/s)Typical Volume (mL)Injection Rate
Pulmonary CTA (CTPA)300-4001.5-2.060-804-5 mL/s
Coronary CTA300-4001.8-2.260-904-6 mL/s
Aortic / Peripheral CTA350-4501.5-2.080-1203-5 mL/s
Abdominal/Pelvic CT400-6001.0-1.580-1202-4 mL/s
Hepatic (late arterial + portal)500-6001.2-1.5100-1503-4 mL/s
Renal CT400-5001.0-1.580-1002-3 mL/s
Low-dose / Follow-up200-3000.8-1.240-602-3 mL/s

Renal Safety: For eGFR < 30 mL/min/1.73m2, consider alternative imaging or dialysis planning. For eGFR 30-44, use minimum diagnostic dose and hydrate. Always follow institutional policy and ACR guidelines.

🛡️
Renal Safety & eGFR Decision Guide
Creatinine, eGFR ranges, and CIN risk assessment
eGFR RangeCKD StageCreatinine ContextCIN Risk GuidanceRecommended Protocol
≥ 60 mL/min/1.73m2 Normal / G1-G2 Typically < 1.2 mg/dL (varies by age/muscle mass) Low CIN risk. Standard hydration and standard contrast dose are acceptable. No special precautions beyond routine protocol. Standard iodinated contrast protocol. Oral or IV hydration per institutional policy.
45 – 59 mL/min/1.73m2 G3a (Mild-Moderate) Elevated but variable; eGFR calculation required Mild CIN risk. Ensure pre- and post-hydration. Use minimum diagnostic iodine dose. Consider iso-osmolar contrast agents. Hydrate before and after exam. Use lowest effective iodine dose. Monitor creatinine 48-72h post-scan if high-risk.
30 – 44 mL/min/1.73m2 G3b (Moderate-Severe) Usually > 1.5 mg/dL; confirm with CKD-EPI Moderate CIN risk. Use minimum diagnostic dose with iso-osmolar agent. Aggressive hydration. Obtain informed consent. Consider alternative imaging (MRI, US). Iso-osmolar contrast preferred. IV hydration (1-1.5 mL/kg/h) before and after. Limit iodine load to < 300 mg I/kg if possible.
15 – 29 mL/min/1.73m2 G4 (Severe) Typically > 2.0–3.0 mg/dL High CIN risk. Strongly consider non-contrast or alternative imaging. If essential, use minimum dose with nephrology consultation. Plan dialysis if applicable. Nephrology consult required. Use absolute minimum diagnostic dose. IV sodium bicarbonate or N-acetylcysteine per protocol. Dialysis planning if on HD.
< 15 mL/min/1.73m2 G5 (Kidney Failure) Usually > 4.0 mg/dL or on dialysis Very high CIN risk. Avoid iodinated contrast unless life-threatening emergency. If on dialysis, contrast can be given with post-procedure dialysis within 24h. Avoid unless absolutely essential. If on HD, schedule dialysis within 24h post-injection. Use minimum dose.
AKI (any eGFR) Acute Kidney Injury Rapidly rising creatinine or oliguria Postpone non-urgent CT. If emergency imaging required, use minimum dose with aggressive hydration. Coordinate with nephrology. Delay elective studies. Use minimum diagnostic dose. Nephrology consult for all emergency cases.

Creatinine Note: Serum creatinine alone is not sufficient for CIN risk stratification because it varies with age, sex, muscle mass, and diet. Always calculate eGFR using the CKD-EPI equation (built into this calculator) before making contrast decisions. For example, a creatinine of 1.2 mg/dL may be normal in a young male but represents eGFR < 60 in an elderly female.

Hydration Protocol: Oral hydration (500 mL water before, 500 mL after) is standard for outpatients. IV hydration with normal saline (1 mL/kg/h for 6-12h before and after) is recommended for inpatients with eGFR < 60. Sodium bicarbonate protocols may be used for high-risk patients per institutional guidelines.

MRI Gadolinium Contrast Calculator

🧬
Patient Parameters
Enter patient data for GBCA dosing
Required for BSA
Required for eGFR
Required for eGFR / NSF risk
Standard fixed dose for comparison

Complete Patient Dose Analysis

📐
Patient Metrics
Body composition & renal function
--BSA (m2)
--eGFR (mL/min/1.73m2)
--Renal Risk / NSF Category
--Agent Stability
🧬
Contrast Dose
Calculated volume & mmol load
--Total Volume (mL)
--Dose (mmol/kg)
--Total mmol
--Vials Needed
📈
AI Injection Profile
Real-time viscosity, velocity & pressure prediction
LIVEViscosityVelocity
GBCA Flow (mL/s)
Saline Flush (mL/s)
Pressure (psi)
Max Pressure Limit
Viscosity (cP)
Velocity (cm/s)
--Total Injection Duration (GBCA + saline)
--Estimated Max Pressure (psi)
--Saline Flush Duration (s)
--Peak Viscosity (cP)
--Peak Velocity (cm/s)
--Reynolds Number
💰
Cost Comparison: Patient-Specific vs Fixed Dose
Per-patient and annual savings analysis
--Fixed Volume (mL)
--Patient Volume (mL)
--Volume Diff
--Fixed Cost
--Patient Cost
--Cost Diff
--Fixed Waste (mL)
--Patient Waste (mL)
--Waste Diff
--Fixed mmol
--Patient mmol
--mmol Diff
--Savings per Patient ($)
--Daily Savings ($)
--Annual Savings ($)
--Annual Volume Saved (L)

Annual Volume Projection per Scanner

--Total Annual Volume (L)
--Total Annual Cost ($)
--Fixed Dose Annual Vol (L)
--Fixed Dose Annual Cost ($)
--Annual Cost Savings ($)
--Annual Volume Saved (L)

Protocol recommendation will appear here.

MRI GBCA Protocol Reference

AgentConcentrationStandard DoseMRA DoseStability
Gadobutrol (Gadovist)1.0 M0.1 mmol/kg0.1-0.2 mmol/kgMacrocyclic
Gadoterate (Dotarem)0.5 M0.1 mmol/kg0.1-0.2 mmol/kgMacrocyclic
Gadobenate (MultiHance)0.5 M0.1 mmol/kg0.1-0.2 mmol/kgLinear
Gadoxetate (Eovist)0.25 M0.025 mmol/kg0.1 mmol/kgLinear
Gadoteridol (ProHance)0.5 M0.1 mmol/kg0.1-0.2 mmol/kgMacrocyclic
Gadopentetate (Magnevist)0.5 M0.1 mmol/kg0.1-0.2 mmol/kgLinear
Gadodiamide (Omniscan)0.5 M0.1 mmol/kg0.1-0.2 mmol/kgLinear
Gadopiclenol (Elucirem)0.5 M0.05 mmol/kg0.1 mmol/kgMacrocyclic (High Relaxivity)
Gadopiclenol (Amblevist)0.5 M0.05 mmol/kg0.1 mmol/kgMacrocyclic (High Relaxivity)

NSF Risk: Avoid linear GBCAs (gadodiamide, gadopentetate, gadobenate, gadoxetate) in patients with eGFR < 30 mL/min/1.73m2 or acute kidney injury. Use macrocyclic agents (gadobutrol, gadoterate, gadoteridol, gadopiclenol) instead. For eGFR 30-59, use lowest diagnostic dose.

🛡️
Renal Safety & eGFR Decision Guide
Creatinine, eGFR ranges, and agent selection
eGFR RangeCKD StageCreatinine ContextGBCA Safety GuidanceRecommended Agents
≥ 60 mL/min/1.73m2 Normal / G1-G2 Typically < 1.2 mg/dL (varies by age/muscle mass) Safe for all GBCAs. No special precautions beyond standard protocol. Monitor for allergic reactions. All agents acceptable. Macrocyclic preferred for repeated dosing.
45 – 59 mL/min/1.73m2 G3a (Mild-Moderate) Elevated but variable; eGFR calculation required Caution. Prefer macrocyclic agents. Use lowest diagnostic dose. Ensure hydration before and after exam. Macrocyclic strongly preferred (gadobutrol, gadoterate, gadoteridol, gadopiclenol).
30 – 44 mL/min/1.73m2 G3b (Moderate-Severe) Usually > 1.5 mg/dL; confirm with CKD-EPI Moderate risk. Avoid linear GBCAs if possible. Use macrocyclic only with minimum dose. Obtain informed consent. Hydrate aggressively. Macrocyclic only (gadobutrol, gadoterate, gadoteridol, gadopiclenol). Avoid linear agents.
15 – 29 mL/min/1.73m2 G4 (Severe) Typically > 2.0–3.0 mg/dL High risk. Avoid linear GBCAs (NSF risk). Macrocyclic agents only with nephrology consultation. Consider dialysis planning if essential. Postpone non-urgent studies. Macrocyclic only with minimum dose. Nephrology consult required.
< 15 mL/min/1.73m2 G5 (Kidney Failure) Usually > 4.0 mg/dL or on dialysis Contraindicated unless life-threatening. Avoid all GBCAs unless absolutely essential. If unavoidable, use macrocyclic with immediate dialysis coordination. Macrocyclic only if essential. Dialysis within 2 hours post-injection if performed.
AKI (any eGFR) Acute Kidney Injury Rapidly rising creatinine or oliguria Postpone non-urgent MRI. If emergency imaging required, use macrocyclic agent at lowest dose. Coordinate with nephrology. Macrocyclic only at lowest diagnostic dose.

Creatinine Note: Serum creatinine alone is not sufficient for risk stratification because it varies with age, sex, muscle mass, and diet. Always calculate eGFR using the CKD-EPI equation (built into this calculator) before making GBCA decisions. For example, a creatinine of 1.2 mg/dL may be normal in a young male but represents eGFR < 60 in an elderly female.

High-Relaxivity Agents: Gadopiclenol (Elucirem, Amblevist) has approximately 2–3× the relaxivity of conventional macrocyclic agents. This allows for a reduced dose (0.05 mmol/kg standard; 0.1 mmol/kg for MRA) while maintaining equivalent or superior enhancement. This is particularly advantageous in patients with renal impairment where minimizing gadolinium exposure is desired.

Explore SATMED Health Solutions

Discover our complete portfolio of medical imaging and patient care products.

Medical Review & Disclaimer: This calculator is intended for educational and workflow optimization purposes only. All contrast doses must be verified by a qualified radiologist or radiology technologist according to institutional protocols, ACR guidelines, and manufacturer prescribing information. This tool does not replace clinical judgment.

Subscribe for Updates!